全文获取类型
收费全文 | 2667篇 |
免费 | 178篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 51篇 |
妇产科学 | 119篇 |
基础医学 | 406篇 |
口腔科学 | 288篇 |
临床医学 | 213篇 |
内科学 | 511篇 |
皮肤病学 | 62篇 |
神经病学 | 188篇 |
特种医学 | 111篇 |
外科学 | 244篇 |
综合类 | 3篇 |
预防医学 | 168篇 |
眼科学 | 23篇 |
药学 | 196篇 |
中国医学 | 18篇 |
肿瘤学 | 225篇 |
出版年
2023年 | 42篇 |
2022年 | 71篇 |
2021年 | 128篇 |
2020年 | 93篇 |
2019年 | 109篇 |
2018年 | 127篇 |
2017年 | 87篇 |
2016年 | 92篇 |
2015年 | 96篇 |
2014年 | 127篇 |
2013年 | 152篇 |
2012年 | 172篇 |
2011年 | 168篇 |
2010年 | 94篇 |
2009年 | 86篇 |
2008年 | 110篇 |
2007年 | 125篇 |
2006年 | 102篇 |
2005年 | 71篇 |
2004年 | 75篇 |
2003年 | 75篇 |
2002年 | 59篇 |
2001年 | 44篇 |
2000年 | 35篇 |
1999年 | 47篇 |
1998年 | 16篇 |
1997年 | 10篇 |
1995年 | 10篇 |
1994年 | 13篇 |
1993年 | 11篇 |
1992年 | 24篇 |
1991年 | 25篇 |
1990年 | 23篇 |
1989年 | 34篇 |
1988年 | 23篇 |
1987年 | 24篇 |
1986年 | 24篇 |
1985年 | 17篇 |
1984年 | 17篇 |
1983年 | 17篇 |
1982年 | 10篇 |
1980年 | 11篇 |
1979年 | 16篇 |
1978年 | 16篇 |
1977年 | 10篇 |
1975年 | 9篇 |
1974年 | 12篇 |
1973年 | 19篇 |
1972年 | 17篇 |
1971年 | 10篇 |
排序方式: 共有2855条查询结果,搜索用时 31 毫秒
1.
2.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98
3.
4.
G M Pacifici A Viani M Franchi S Santerini A Temellini L Giuliani M Carrai 《British journal of clinical pharmacology》1990,30(3):427-435
1. The activities of microsomal glucuronyltransferase and thiomethyltransferase, and those of cytosolic sulphotransferase, acetyltransferase, glutathione transferase and thiomethyltransferase were measured in abnormal (cirrhosis and chronic hepatitis) and normal livers. 2. Glucuronyltransferase and sulphotransferase were investigated with 2-naphthol and ethinyloestradiol as substrates. p-Aminobenzoic acid, benzo(a)pyrene-4,5-epoxide and 2-mercaptoethanol were the substrates of acetyltransferase, glutathione transferase and thiomethyltransferase, respectively. 3. Enzyme activities are expressed as nmol min-1 incubation mg-1 protein and the averages (+/- s.d.) are given. With 2-naphthol as substrate, the glucuronyltransferase activity was 6.55 +/- 4.10 (abnormal liver, n = 33) and 7.81 +/- 4.02 (normal liver, n = 26) (NS); whereas sulphotransferase activity was 0.28 +/- 0.18 (abnormal liver, n = 35) and 0.68 +/- 0.43 (normal liver, n = 26) (P less than 0.01). Glucuronyltransferase activity towards ethinyloestradiol was 102.5 +/- 56.9 (abnormal liver, n = 30) and 107 +/- 59.9 (normal liver, n = 26) (NS), whereas sulphotransferase activity was 57.2 +/- 36.0 (abnormal liver, n = 35) and 122 +/- 67.6 (normal liver, n = 28) (P less than 0.01). Acetyltransferase activity was 0.84 +/- 0.83 (abnormal liver, n = 35) and 3.84 +/- 1.65 (normal liver, n = 26) (P less than 0.01). Glutathione transferase activity was 0.83 +/- 0.68 (abnormal liver, n = 35) and 2.90 +/- 1.59 (normal liver, n = 25) (P less than 0.01) and thiomethyltransferase activity was 1.00 +/- 0.69 (abnormal liver, n = 34) and 3.99 +/- 1.49 (normal liver, n = 25) (P less than 0.01). 4. Liver disease lowers the activities towards the substrates studied of sulphotransferase, acetyltransferase, glutathionetransferase and thiomethyltransferase but not that of glucuronyltransferase.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
5.
L Padeletti A Michelucci T Giovannini A Mezzani A Monopoli F Franchi 《Giornale italiano di cardiologia》1989,19(5):411-416
Programmed atrial stimulation at five atrial sites was performed to evaluate electrophysiologic atrial properties in 17 control patients (14 M, 3F, mean age 61 +/- 9 years) (Group A) and in 18 patients with paroxysmal atrial fibrillation (13 M, 5 F, mean age 61 +/- 5 years) (Group B) with normal sinus node function. The mean value of the P wave duration was similar in both groups. Programmed atrial stimulation was performed at five atrial sites: high, medium and low lateral wall, and high and low medial wall. We evaluated the following parameters: A) local conduction delay measured at the functional refractory period as the difference between A1-A2 and S1-S2 intervals; B) widening of local electrogram measured at the functional refractory period as the difference between A1-A2 interval measured at the end of each local electrogram and A1-A2 interval measured at the beginning of each local electrogram. We evaluated the mean and the maximum value of the two above-mentioned parameters; C) dispersion of effective refractory period and functional refractory period, determined as the longest minus the shortest refractory period from the range of refractory periods measured in each patient; D) the mean of effective refractory periods and functional refractory periods observed at five atrial sites. Mean and maximum local conduction delay, mean effective and functional refractory periods did not present significant differences in both groups.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
6.
Pain management in ambulatory surgery. 总被引:1,自引:0,他引:1
Damon Kamming Frances Chung Donna Williams Brid M McGrath Bruna Curti 《Journal of PeriAnesthesia Nursing》2004,19(3):174-182
Successful ambulatory surgery is dependent on analgesia that is effective, has minimal adverse effects, and can be safely managed by the patient at home after discharge. A number of studies have identified that the provision of effective postoperative analgesia is inadequate for a significant proportion of patients. The following discussion details the current available analgesic options for ambulatory surgery patients and the rationale for their use. Preemptive analgesia should be given to all patients unless there are specific contraindications. Consideration should be given to the use of long-acting oral COX-2 selective nonsteroidal anti-inflammatory drugs (NSAIDs) and long-acting oral opioids to treat postoperative pain. A standardized multimodal postdischarge analgesic regimen tailored to the patient's expected postoperative pain levels should be prescribed. Patient follow-up by telephone questionnaire will confirm those surgical procedures that result in mild or moderate-to-severe postoperative pain and the effectiveness of treatment plans. 相似文献
7.
8.
9.
S. Stegemann F. Leveiller D. Franchi H. de Jong H. Lindn 《European journal of pharmaceutical sciences》2007,31(5):249-261
Drug absorption, sufficient and reproducible bioavailability and/or pharmacokinetic profile in humans are recognized today as one of the major challenges in oral delivery of new drug substances. The issue arose especially when drug discovery and medicinal chemistry moved from wet chemistry to combinatorial chemistry and high throughput screening in the mid-1990s. Taking into account the drug product development times of 8–12 years, the apparent R&D productivity gap as determined by the number of products in late stage clinical development today, is the result of the drug discovery and formulation development in the late 1990s, which were the early and enthusiastic times of the combinatorial chemistry and high throughput screening. In parallel to implementation of these new technologies, tremendous knowledge has been accumulated on biological factors like transporters, metabolizing enzymes and efflux systems as well as on the physicochemical characteristics of the drug substances like crystal structures and salt formation impacting oral bioavailability. Research tools and technologies have been, are and will be developed to assess the impact of these factors on drug absorption for the new chemical entities.
The conference focused specifically on the impact of compounds with poor solubility on analytical evaluation, prediction of oral absorption, substance selection, material and formulation strategies and development. The existing tools and technologies, their potential utilization throughout the drug development process and the directions for further research to overcome existing gaps and influence these drug characteristics were discussed in detail. 相似文献
10.